Plasmid pCMV·SPORT-bgal is used as a positive control formonitoring expression in eukaryotic cells. The plasmid contains thereporter gene b-galactosidase (b-gal)深入閱讀
Have Questions?
產品號碼
Quantity
10586014
25 μg
產品號碼 10586014
價格 (TWD)
19,810.00
線上優惠
Ends: 31-Dec-2025
28,300.00
您節省 8,490.00 (30%)
Each
新增至購物車
Quantity:
25 μg
價格 (TWD)
19,810.00
線上優惠
Ends: 31-Dec-2025
28,300.00
您節省 8,490.00 (30%)
Each
新增至購物車
Plasmid pCMV·SPORT-bgal is used as a positive control for monitoring expression in eukaryotic cells. The plasmid contains the reporter gene b-galactosidase (b-gal) from E. coli cloned as a Not I fragment into plasmid pCMV·SPORT1. The plasmid also contains a CMV promoter upstream of the b-gal gene, followed by the SV40 t-intron and polyadenylation signal. The b-lactamase gene allows selection for ampicillin resistance in E. coli.
For Research Use Only. Not for use in diagnostic procedures.
規格
Constitutive or Inducible SystemConstitutive
Delivery TypeTransfection
For Use With (Application)Reporter Assays, Constitutive Expression
Product TypePlasmid
Quantity25 μg
Reporter GeneBeta-Gal (lacZ)
Selection Agent (Eukaryotic)None
Shipping ConditionApproved for shipment on Wet or Dry Ice
VectorpCMV
PromoterCMV
Protein TagUntagged
Unit SizeEach
內容物與存放
Store at +4°C. Store at -20°C long term.
常見問答集 (常見問題)
How do I resuspend IPTG and X-Gal?
IPTG can be reconstituted in water. Make a stock of 100 mM in water and store working aliquots at -20°C. X-gal can be reconstituted in DMSO, or in a 50:50 mix of DMSO and water. To do the latter, you must dissolve in DMSO first, and then add water to bring up to final volume. It is not necessary to filter sterilize these solutions.
The X-gal solution should be protected from light. To make plates, add 50 ug/ml X-gal and 1 mM (0.24 mg/mL) IPTG to LB/agar that has been cooled down to 50°C. To spread on top of plates, use 50 µl 2% stock of X-gal and 30 µl 100 mM stock of IPTG.
I sequenced one of your vectors after PCR amplification and observed a difference from what is provided online (or in the manual). Should I be concerned?
Our vectors have not been completely sequenced. Your sequence data may differ when compared to what is provided. Known mutations that do not affect the function of the vector are annotated in public databases.
Are your vectors routinely sequenced?
No, our vectors are not routinely sequenced. Quality control and release criteria utilize other methods.
How was the reference sequence for your vectors created?
Sequences provided for our vectors have been compiled from information in sequence databases, published sequences, and other sources.
引用資料與參考文獻 (1)
引用資料與參考文獻
Abstract
TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.
Authors: Li Xiaoming; Yang Yili; Ashwell Jonathan D;
Journal:Nature
PubMed ID:11907583
Tumour necrosis factor-alpha (TNF-alpha) is a proinflammatory mediator that exerts its biological functions by binding two TNF receptors (TNF-RI and TNF-RII), which initiate biological responses by interacting with adaptor and signalling proteins. Among the signalling components that associate with TNF receptors are members of the TNF-R-associated factor (TRAF) family. TRAF2 ... More